Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Dec 2023 for Annexin Pharmaceuticals AB, €8,873.
Filing timeline
BuySaleCarl-Fredrik Lindner
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Carl-Fredrik Lindner: trading record in brief
One trade, one date: on 18 December 2023, Carl-Fredrik Lindner disclosed an open-market purchase of €8,873 in Annexin Pharmaceuticals AB. No broader history exists yet. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Carl-Fredrik Lindner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 500,005 shares@ SEK 0.20100.0% of flowTeckningsrätt/UniträttISIN SE0021148699FI:csv-fed0d4d2c027a826f4b6Canonical exit: 14 Mar 2024 (T+90)
1 of 1 declaration